Company evaluating systemic recombinant human DNase I (DNase I) in combination with chemotherapy and immunotherapy platforms for the treatment of pancreatic carcinoma, colorectal cancer and other ...
The following slide deck was published by AtaiBeckley Inc. in conjunction with this event.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results